Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine

References

• HazardEMunakataJBigalMERupnowMFLiptonRBThe burden of migraine in the United States: current and emerging perspectives on disease management and economic analysisValue Health2009121556418671771
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society (IHS)The International Classification of Headache Disorders, 3rd edition (beta version)Cephalalgia201333962980823771276
   PubMed Web of Science ®Google Scholar
• MartinVTLiptonRBEpidemiology and biology of menstrual migraineHeadache200848Suppl 3S124S13019076658
   PubMedGoogle Scholar
• LiptonRBStewartWFStoneAMLainezMJSawyerJPDisability in Strategies of Care Group. Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: 4. A randomized trialJAMA2000284202599260511086366
   PubMed Web of Science ®Google Scholar
• SarchielliPGranellaFPrudenzanoMPItalian guidelines for primary headaches: 2012 revised versionJ Headache Pain201213Suppl 2S31S7022581120
   PubMed Web of Science ®Google Scholar
• JohnstonMMRapoportAMTriptans for the management of migraineDrugs201070121505151820687618
   PubMed Web of Science ®Google Scholar
• LoderETriptan therapy in migraineN Engl J Med20103631637020592298
   PubMed Web of Science ®Google Scholar
• EversSLisottoCAn algorithm of migraine treatmentEur Neurol Rev201382149152
   Google Scholar
• BalbisiEAFrovatriptan: a review of pharmacology, pharmacokinetics and clinical potential in the treatment of menstrual migraineTher Clin Risk Manag20062330330818360605
   PubMedGoogle Scholar
• BalbisiEAFrovatriptan succinate, a 5-HT1B/1D receptor agonist for migraineInt J Clin Pract200458769570515311727
   PubMed Web of Science ®Google Scholar
• CadyRKBanksJJonesBACampbellJPostmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combinationCurr Med Res Opin200925112711272119778164
   PubMed Web of Science ®Google Scholar
• PoolsupNLeelasangalukVJittangtrongJRithlamlertCRatanapantamaneeNKhanthongMEfficacy and tolerability of frovatriptan in acute migraine treatment: systematic review of randomized controlled trialsJ Clin Pharm Ther200530652153216336284
   PubMed Web of Science ®Google Scholar
• SaviLOmboniSLisottoCA double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraineJ Headache Pain201112221922620686810
   PubMed Web of Science ®Google Scholar
• TulloVAllaisGFerrariMDFrovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian studyNeurol Sci201031Suppl 1S51S5420464583
   PubMed Web of Science ®Google Scholar
• BartoliniMGiamberardinoMALisottoCA double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraineJ Headache Pain201112336136821437714
   PubMed Web of Science ®Google Scholar
• SaviLOmboniSLisottoCEfficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptanJ Headache Pain201112660961521842274
   PubMed Web of Science ®Google Scholar
• AllaisGTulloVBenedettoCZavaDOmboniSBussoneGEfficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, multicenter, Italian, comparative study versus zolmitriptanNeurol Sci201132Suppl 1S99S10421533723
   PubMed Web of Science ®Google Scholar
• BartoliniMGiamberardinoMALisottoCFrovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative studyJ Headache Pain201213540140622592864
   PubMed Web of Science ®Google Scholar
• AllaisGTulloVOmboniSEfficacy of frovatriptan versus other triptans in the acute treatment of menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studiesNeurol Sci201233Suppl 1S65S6922644174
   PubMed Web of Science ®Google Scholar
• AllaisGTulloVOmboniSFrovatriptan vs other triptans for the acute treatment of oral contraceptive-induced menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studiesNeurol Sci201334Suppl 1S83S8623695052
   PubMed Web of Science ®Google Scholar
• TulloVBussoneGOmboniSEfficacy of frovatriptan and other triptans in the treatment of acute migraine of hypertensive and normotensive subjects: a review of randomized studiesNeurol Sci201334Suppl 1S87S9123695053
   PubMed Web of Science ®Google Scholar
• SaraccoMGAllaisGTulloVEfficacy of frovatriptan and other triptans in the treatment of acute migraine of normal weight and obese subjects: a review of randomized studiesNeurol Sci201435Suppl 111511924867847
   PubMed Web of Science ®Google Scholar
• LisottoCSaviLPinessiLGuidottiMOmboniSZanchinGEfficacy of frovatriptan vs other triptans in weekend migraine: Pooled analysis of three double-blind, randomized, crossover, multicenter studiesBrain Disord Ther20143128
   Google Scholar
• EversSSaviLOmboniSLisottoCZanchinGPinessiLEfficacy of frovatriptan as compared to other triptans in migraine with auraJ Headache Pain20151651425916333
   PubMed Web of Science ®Google Scholar
• TulloVAllaisGCuroneMFrovatriptan versus zolmitriptan for the acute treatment of migraine with aura: a double-blind, randomized, multicenter, Italian studyNeurol Sci201233Suppl 1S61S6422644173
   PubMedGoogle Scholar
• AllaisGTulloVCortelliPEfficacy of early vs late use of frovatriptan combined with dexketoprofen vs frovatriptan alone in the acute treatment of migraine attacks with or without auraNeurol Sci201435Suppl 110711324867846
   PubMedGoogle Scholar
• AllaisGBussoneGTulloVEarly (</=1-h) vs late (>1-h) administration of frovatriptan plus dexketoprofen combination vs frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group studyNeurol Sci201536Suppl 1161167
   PubMedGoogle Scholar
• TulloVValguarneraFBarbantiPComparison of frovatriptan plus dexketoprofen (25 mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: a randomized studyCephalalgia201434643444524363238
   PubMed Web of Science ®Google Scholar
• Headache Classification Subcommittee of the International Headache SocietyThe International Classification of Headache Disorders: 2nd editionCephalalgia200424Suppl 1916014979299
   PubMed Web of Science ®Google Scholar
• CortelliPAllaisGTulloVFrovatriptan versus other triptans in the acute treatment of migraine: pooled analysis of three double-blind, randomized, cross-over, multicenter, Italian studiesNeurol Sci201132Suppl 1S95S9821533722
   PubMed Web of Science ®Google Scholar
• AllaisGBenedettoCA review of the use of frovatriptan in the treatment of menstrually related migraineTher Adv Neurol Disord201362556723483096
   PubMed Web of Science ®Google Scholar
• AllaisGCastagnoli GabellariIDe LorenzoCManaOBenedettoCMenstrual migraine: clinical and therapeutical aspectsExpert Rev Neurother2007791105112017868010
   PubMedGoogle Scholar
• RecoberAGewekeLOMenstrual migraineCurr Neurol Neurosci Rep200552939815743545
   PubMedGoogle Scholar
• MacGregorEAPrevention and treatment of menstrual migraineDrugs201070141799181820836574
   PubMed Web of Science ®Google Scholar
• Migard SPC 2014Migard SPC 2014 Available from: https://www.medicines.org.uk/emc/medicine/15216Accessed November 1, 2015
   Google Scholar
• SilbersteinSDHollandSFreitagFDodickDWArgoffCAshmanEEvidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache SocietyNeurology201278171337134522529202
   PubMed Web of Science ®Google Scholar
• MainardiFMaggioniFPezzolaDZavaDZanchinGDexketoprofen trometamol in the acute treatment of migraine attack: a phase II, randomized, double-blind, crossover, placebo-controlled, dose optimization studyJ Pain201415438839424412801
   PubMed Web of Science ®Google Scholar
• AllaisGDe LorenzoCAirolaGPeanoSBenedettoCDexketoprofen trometamol in the treatment of acute migraine attackMinerva Med2000917–815315911155464
   PubMedGoogle Scholar
• D’AmicoDMoschianoFBussoneGEarly treatment of migraine attacks with triptans: a strategy to enhance outcomes and patient satisfaction?Expert Rev Neurother2006671087109716831121
   PubMedGoogle Scholar
• HautSDifferentiating migraine from epilepsyAdv Stud Med200556ES658S665
   Google Scholar
• BarbantiPAuriliaCEgeoGFofiLHypertension as a risk factor for migraine chronificationNeurol Sci201031Suppl 1S41S4320464581
   PubMed Web of Science ®Google Scholar
• BigalMELiptonRBHollandPRGoadsbyPJObesity, migraine, and chronic migraine: possible mechanisms of interactionNeurology200768211851186117515549
   PubMed Web of Science ®Google Scholar
• PeresMFLerarioDDGarridoABZukermanEPrimary headaches in obese patientsArq Neuropsiquiatr200563493193316400407
   PubMed Web of Science ®Google Scholar
• GuidottiMBarrilaCLevaSDePCOmboniSSymptomatic or prophylactic treatment of weekend migraine: an open-label, nonrandomized, comparison study of frovatriptan versus naproxen sodium versus no therapyNeuropsychiatr Dis Treat20139818523355779
   PubMed Web of Science ®Google Scholar
• PeterlinBLGuptaSWardTNMacgregorASex matters: evaluating sex and gender in migraine and headache researchHeadache201151683984221631471
   PubMed Web of Science ®Google Scholar
• FranconiFFinocchiCAllaisGGender and triptan efficacy: a pooled analysis of three double-blind, randomized, crossover, multicenter, Italian studies comparing frovatriptan vs other triptansNeurol Sci201435Suppl 199105
   PubMedGoogle Scholar
• GeraudGSpieringsELKeywoodCTolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptanHeadache200242Suppl 2S93S9912028325
   PubMed Web of Science ®Google Scholar
• EdmeadsJMackellJAThe economic impact of migraine: an analysis of direct and indirect costsHeadache200242650150912167138
   PubMed Web of Science ®Google Scholar
• LisottoCGuidottiMZavaDSaviLFrovatriptan and rizatriptan economic EVAluation: the FREEVA studyJ Headache Pain2013149624330707
   PubMedGoogle Scholar
• Sonal SekharMSasidharanSJosephSKumarAMigraine management: How do the adult and paediatric migraines differ?Saudi Pharm J20122011723960771
   PubMed Web of Science ®Google Scholar
• GallelliLAvenosoTFalconeDEffects of acetaminophen and ibuprofen in children with migraine receiving preventive treatment with magnesiumHeadache201454231332423808884
   PubMed Web of Science ®Google Scholar
• TepperSJClinical implications for breath-powered powder sumatriptan intranasal treatmentHeadache20135381341134923809006
   PubMed Web of Science ®Google Scholar
• ElkindAHWadeAIshkanianGPharmacokinetics of frovatriptan in adolescent migraineursJ Clin Pharmacol200444101158116515342617
   PubMed Web of Science ®Google Scholar
• EspositoMCarotenutoMGinkgolide B complex efficacy for brief prophylaxis of migraine in school-aged children: an open-label studyNeurol Sci2011321798120872034
   PubMed Web of Science ®Google Scholar
• EspositoMRubertoMPascottoACarotenutoMNutraceutical preparations in childhood migraine prophylaxis: effects on headache outcomes including disability and behaviourNeurol Sci20123361365136822437495
   PubMed Web of Science ®Google Scholar
• VerrottiAAgostinelliSD’EgidioCImpact of a weight loss program on migraine in obese adolescentsEur J Neurol201320239439722642299
   PubMed Web of Science ®Google Scholar
• VerrottiACarotenutoMAltieriLMigraine and obesity: metabolic parameters and response to a weight loss programmePediatr Obes201510322022524990114
   PubMed Web of Science ®Google Scholar
• ComerMBPharmacology of the selective 5-HT(1B/1D) agonist frovatriptanHeadache200242Suppl 2S47S5312028320
   PubMed Web of Science ®Google Scholar